MOLECULAR TEMPLATES INC's ticker is MTEM and the CUSIP is 608550109. A total of 92 filers reported holding MOLECULAR TEMPLATES INC in Q1 2020. The put-call ratio across all filers is 1.76 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 303 | -98.4% | 0.00% | – |
| Q1 2022 | $66,000 | -10.8% | 19,003 | 0.0% | 0.00% | – |
| Q4 2021 | $74,000 | -42.2% | 19,003 | -0.3% | 0.00% | – |
| Q3 2021 | $128,000 | -48.6% | 19,067 | -40.1% | 0.00% | – |
| Q2 2021 | $249,000 | +7.3% | 31,814 | +72.9% | 0.00% | – |
| Q1 2021 | $232,000 | +90.2% | 18,400 | +41.5% | 0.00% | – |
| Q4 2020 | $122,000 | -54.5% | 13,000 | -46.9% | 0.00% | – |
| Q3 2020 | $268,000 | -20.7% | 24,500 | 0.0% | 0.00% | – |
| Q2 2020 | $338,000 | +45.1% | 24,500 | +40.0% | 0.00% | – |
| Q1 2020 | $233,000 | -4.9% | 17,500 | 0.0% | 0.00% | – |
| Q4 2019 | $245,000 | +288.9% | 17,500 | +84.2% | 0.00% | – |
| Q3 2019 | $63,000 | -20.3% | 9,500 | 0.0% | 0.00% | – |
| Q2 2019 | $79,000 | +43.6% | 9,500 | 0.0% | 0.00% | – |
| Q1 2019 | $55,000 | +44.7% | 9,500 | 0.0% | 0.00% | – |
| Q4 2018 | $38,000 | -25.5% | 9,500 | 0.0% | 0.00% | – |
| Q3 2018 | $51,000 | +2.0% | 9,500 | 0.0% | 0.00% | – |
| Q2 2018 | $50,000 | – | 9,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,137,991 | $8,381,000 | 6.85% |
| ACUTA CAPITAL PARTNERS, LLC | 322,500 | $1,264,000 | 0.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,021,317 | $4,004,000 | 0.46% |
| BVF INC/IL | 3,129,599 | $12,268,000 | 0.44% |
| Bellevue Group AG | 10,878,003 | $42,642,000 | 0.44% |
| FRAZIER MANAGEMENT LLC | 1,374,047 | $5,386,000 | 0.42% |
| Endurant Capital Management LP | 268,375 | $1,052,000 | 0.25% |
| Abingworth LLP | 200,000 | $780,000 | 0.19% |
| Parkman Healthcare Partners LLC | 147,728 | $579,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 145,329 | $570,000 | 0.07% |